SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?


To: E. Graphs who wrote (623)4/20/1998 2:40:00 PM
From: Sleepman  Read Replies (2) | Respond to of 834
 
The spike interest was probably generated by the Nightly Business Report on Friday. Apparently some nice things were said about TXB.
That being said, I think that once the anticoagulant gets approved and on the market, we'll see what this can really do. Many in medicine think that the thrombin inhibitors will be the way to go in anticoagulation. This one, being the first that I know about should take the lead. Dan